Last reviewed · How we verify
Inhalational anthrax
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Doxycyclin · Bulovka Hospital
- Penicillin G Potassium In Plastic Container · Pfizer
- Anthim · Elusys Therapeutics Inc
Anthim works by binding to the protective antigen of anthrax toxin, neutralizing its effects. - Vibramycin · Generic (originally Pfizer)
- penicillin · Karlstad University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Inhalational anthrax patent landscape — cliff calendar, originator estates, attackable patents
- Inhalational anthrax treatment landscape brief
- Inhalational anthrax treatment updates RSS
Frequently asked questions about Inhalational anthrax
What drugs treat Inhalational anthrax?
Tracked treatments include Ramycin, Doxycyclin, Penicillin G Potassium In Plastic Container, Anthim, Vibramycin, penicillin.
What is the treatment for Inhalational anthrax?
Standard treatment for Inhalational anthrax includes Ramycin, Doxycyclin, Penicillin G Potassium In Plastic Container, Anthim, Vibramycin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Inhalational anthrax patent cliff · Inhalational anthrax CI report
- Treatment: Ramycin
- Treatment: Doxycyclin · Bulovka Hospital
- Treatment: Penicillin G Potassium In Plastic Container · Pfizer
- Treatment: Anthim · Elusys Therapeutics Inc
- Treatment: Vibramycin · Generic (originally Pfizer)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing